Affymax to look hard at safety of its anemia drug

(Reuters) - The biotechnology company is about to enter late-stage
trials of its drug Hematide, in patients with chronic kidney
disease. Morris said the company hopes to file for approval of
the drug in 2010.




Read more at Reuters.com Government Filings News